Sleep and Pain in Sickle Cell Disease

About the study

This is a study testing the effects of behavioral sleep interventions on pain and brain function in sickle cell disease.

Study point of contact

Jennifer Haythornthwaite, PhD
410-550-7000
[email protected]
Claudia Campbell, PhD
410-550-7989
[email protected]

Locations

1 United States site

Age

18 to 100 Years

Genotypes

Hemoglobin SC

Phase

Not Applicable

Study type

Interventional

Age

18 Years - 100 Years

Gender

All

Interventions

Behavioral

Other

Compensation

Unknown

participation requirements

Diagnosis of sickle cell hemoglobinopathy (Homozygous sickle cell disease, Hemoglobin SC disease, or Sickle/beta-thalassemia);
Adequate facility with English;
Stable dosing of medications (if taking) for pain and sleep;
Reports symptoms of insomnia;
Reports chronic pain

participation restrictions

Cognitive impairment;
Unstable psychiatric disorder;
Seizure disorder;
Positive pregnancy or drug test

Locations

  • Baltimore, Maryland, United States, Johns Hopkins, 21224 [Recruiting]
Last updated 2021-07-15